Mettler-Toledo International (NYSE:MTD – Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 47.150-47.500 for the period, compared to the consensus estimate of 46.640. The company issued revenue guidance of $4.2 billion-$4.2 billion, compared to the consensus revenue estimate of $4.2 billion. Mettler-Toledo International also updated its Q3 2026 guidance to 12.000-12.150 EPS.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on MTD shares. Barclays cut their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Weiss Ratings cut Mettler-Toledo International from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday, July 21st. Morgan Stanley lowered their target price on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating for the company in a report on Tuesday, May 12th. Wall Street Zen downgraded shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Saturday, May 16th. Finally, Robert W. Baird dropped their price target on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $1,420.36.
Mettler-Toledo International Trading Up 2.7%
Mettler-Toledo International (NYSE:MTD – Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $11.46 earnings per share for the quarter, beating analysts’ consensus estimates of $10.80 by $0.66. The company had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.03 billion. Mettler-Toledo International had a negative return on equity of 872.07% and a net margin of 21.91%.The firm’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $10.09 EPS. Mettler-Toledo International has set its FY 2026 guidance at 47.150-47.500 EPS and its Q3 2026 guidance at 12.000-12.150 EPS. Research analysts expect that Mettler-Toledo International will post 46.63 EPS for the current year.
Key Headlines Impacting Mettler-Toledo International
Here are the key news stories impacting Mettler-Toledo International this week:
- Positive Sentiment: Quarterly earnings beat expectations: Adjusted EPS rose 14% year over year to $11.46, exceeding the $10.80 consensus estimate by $0.66. Revenue increased approximately 4% to $1.03 billion, in line with expectations, while reported EPS reached $11.55 versus $9.76 a year earlier. Mettler-Toledo Second-Quarter 2026 Results
- Positive Sentiment: Full-year outlook was raised: Mettler-Toledo now expects fiscal 2026 EPS of $47.15 to $47.50, above the prior consensus estimate of $46.64. The updated outlook supports expectations for continued earnings growth and helped strengthen the investment case. Mettler-Toledo Second-Quarter 2026 Results
- Positive Sentiment: Jefferies became more bullish: Jefferies Financial Group raised its price target from $1,400 to $1,580 and upgraded the stock to “buy,” implying roughly 11% upside from the referenced trading level. The upgrade provides additional positive analyst momentum. Benzinga analyst-upgrade report
- Neutral Sentiment: Third-quarter guidance was broadly in line: EPS guidance of $12.00 to $12.15 brackets the $12.12 consensus estimate, while revenue guidance of approximately $1.1 billion is consistent with expectations. This suggests steady performance but provides less of a near-term upside surprise than the full-year outlook.
Hedge Funds Weigh In On Mettler-Toledo International
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Geneos Wealth Management Inc. lifted its stake in Mettler-Toledo International by 83.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after acquiring an additional 30 shares in the last quarter. Baird Financial Group Inc. raised its position in shares of Mettler-Toledo International by 3.1% in the second quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock valued at $1,582,000 after purchasing an additional 40 shares during the period. Jump Financial LLC boosted its holdings in shares of Mettler-Toledo International by 44.6% during the 2nd quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock worth $476,000 after buying an additional 125 shares during the period. Cerity Partners LLC boosted its holdings in Mettler-Toledo International by 10.8% during the second quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock valued at $4,740,000 after acquiring an additional 392 shares during the period. Finally, AXA S.A. increased its stake in shares of Mettler-Toledo International by 2.9% in the second quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock worth $5,433,000 after purchasing an additional 131 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.
About Mettler-Toledo International
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Further Reading
- Five stocks we like better than Mettler-Toledo International
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
- MarketBeat Week in Review – 07/27- 07/31
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
